Image
ADHD Ready banner
Image
ADHD_ready_Mobile

19 August 2026
06:30 PM - 09:00 PM
Place
Rydges South Bank Brisbane
Podium Rooms 1 & 2
9 Glenelg St, South Brisbane QLD 4101
Organizer
Novartis In-Market Brands
2026-08-19T18:30:00 2026-08-19T21:00:00 ADHD Ready - Accelerating Skills for General Practice (Brisbane) Rydges South Bank Brisbane Novartis One CMS [email protected] Add to my Calendar

ADHD Ready: Accelerating Skills for General Practice (In-person/Virtual)

 

ADHD care in Australia is undergoing significant transformation. With evolving prescribing frameworks and an expanding role for general practice, many GPs are adapting to new assessment and initiation pathways.

With this in mind, we are pleased to invite you to attend ADHD Ready: Accelerating Skills for General Practice, a hybrid educational meeting series designed to support GPs in the management of Attention‑Deficit/Hyperactivity Disorder (ADHD).

During this session, Dr Christopher Soo will provide practical guidance on ADHD assessment in general practice, including the use of structured checklists, and key diagnostic considerations. The meeting will also cover initiation and titration of stimulant therapy, indicators for treatment adjustment, clear thresholds for reassessment or referral, and approaches to building shared‑care.

We look forward to welcoming you and supporting your ongoing clinical practice through this educational series.

Please note that local delegates will be able to attend in person, and a live‑stream of the meeting will be available for those who prefer to join virtually.

Agenda

  • 06:30 07:00 PM

    Arrival and Registrations
    07:00 07:05 PM

    Welcome and Introductions
    07:05 07:45 PM

    Recognition and diagnosis of ADHD across the lifespan
    07:45 08:25 PM

    Treatment planning and ongoing patient management
    08:25 08:55 PM

    Q&A
    08:55 09:00 PM

    Close
Speakers
Dr Christopher Soo
dr
Christopher
Soo

Register now

 

Please provide your details so that we can register your attendance.

Will you be joining in-person or virtually?
Link: https://us02web.zoom.us/webinar/register/WN_HIwL2XEYSTGk3QkIMrsa-Q
For in‑person attendance, please indicate any dietary requirements.
Do you require parking?
Complimentary parking at the Brisbane Convention Centre (via Merivale Street) will be provided for all local guests attending.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Parking Details

Complimentary parking at the Brisbane Convention Centre (via Merivale Street) will be provided for all local guests attending.

Instructions:

  • Enter car park via Merivale St and take a ticket
  • Park anywhere (CP2 and CP3 closest to venue)
  • Walk towards exits onto Russell St, turn right onto Grey St and walk down to Rydges South Bank Brisbane (4 min walk)
  • At the Novartis registration desk, swap entry ticket for a prepaid ticket
  • Exit by entering prepaid ticket

Ritalin 10/Ritalin LA Warning – DRUG DEPENDENCE: Ritalin should be given cautiously to patients with a history of drug dependence or alcoholism. Chronic abusive use can lead to marked tolerance and psychological dependence with varying degrees of abnormal behaviour. Frank psychotic episodes can occur, especially with parenteral abuse. Careful supervision is required during withdrawal from abusive use since severe depression may occur. Withdrawal following chronic therapeutic use may unmask symptoms of the underlying disorder that may require follow up.

PBS Information – Ritalin 10: Authority required. Use in attention deficit hyperactivity disorder, in accordance with State/Territory law. Refer to PBS Schedule for full Authority required information.

PBS Information – Ritalin LA: Authority required. Treatment of attention deficit hyperactivity disorder (ADHD) in a patient diagnosed between the ages of 6 and 18 years inclusive, or a patient who had a retrospective diagnosis of ADHD if PBS-subsidised treatment is commencing after turning 18 years of age. Patient must have demonstrated a response to immediate release methylphenidate hydrochloride with no emergence of serious adverse events, and who requires continuous coverage over 8 hours. Refer to PBS Schedule for full Authority required information.

 

For healthcare professionals only.
Please review Product Information before prescribing. 

For full RITALIN 10/LA (methylphenidate) Product Information please click here.

 

For more information or to report any adverse events, please contact Novartis Australia Medical Information on 1800 671 203 or email [email protected]

For medical enquiries please contact 1800 671 203.
Novartis Pharmaceuticals Australia Pty Limited ABN 18 004 244 160.
Sydney NSW. Ph (02) 9805 3555.
® Registered Trademark 

Terms of Use | Data Privacy


Tags

AU-30592, May 2026